Skandinaviska Enskilda Banken Ab (Publ) Bluebird Bio, Inc. Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

  • $21.5 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022
SELL
$8.96 - $16.31 $160,384 - $291,949
-17,900 Closed
0 $0
Q3 2021

Nov 10, 2021
BUY
$11.24 - $21.0 $201,196 - $375,900
17,900 New
17,900 $342,000
Q3 2020

Nov 12, 2020
SELL
$34.44 - $43.75 $127,427 - $161,875
-3,700 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$27.12 - $45.97 $100,344 - $170,089
3,700 New
3,700 $226,000

Others Institutions Holding BLUE

# of Institutions
146
Shares Held
63.3M
Call Options Held
264K
Put Options Held
428K
View Full List

About bluebird bio, Inc.

BLUE Quotes by TradingView
  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $644M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Skandinaviska Enskilda Banken Ab (Publ) Portfolio

Follow Skandinaviska Enskilda Banken Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email